about
Critical determinants of uptake and translocation of nanoparticles by the human pulmonary alveolar epitheliumAdvances in device and formulation technologies for pulmonary drug delivery.Academic pharmacy strikes Hawai'i. Part 2.Isoniazid-gelatin conjugate microparticles containing rifampicin for the treatment of tuberculosis.STAT6 siRNA matrix-loaded gelatin nanocarriers: formulation, characterization, and ex vivo proof of concept using adenocarcinoma cellsDifferential bioreactivity of neutral, cationic and anionic polystyrene nanoparticles with cells from the human alveolar compartment: robust response of alveolar type 1 epithelial cellsDevelopment of Optimized, Inhalable, Gemcitabine-Loaded Gelatin Nanocarriers for Lung Cancer.Berberine hydrochloride: anticancer activity and nanoparticulate delivery system.Liposomes as drug delivery systems for the treatment of TB.Therapeutic liposomal dry powder inhalation aerosols for targeted lung delivery.Engineered PLGA nano- and micro-carriers for pulmonary delivery: challenges and promises.Generation of tailored aerosols for inhalative drug delivery employing recent vibrating-mesh nebulizer systems.Formulation development and evaluation of hybrid nanocarrier for cancer therapy: Taguchi orthogonal array based design.In vivo imaging using polymeric nanoparticles stained with near-infrared chemiluminescent and fluorescent squaraine catenane endoperoxide.The impact of microfluidic mixing of triblock micelleplexes on in vitro / in vivo gene silencing and intracellular trafficking.Inhaled sildenafil nanocomposites: lung accumulation and pulmonary pharmacokinetics.Composition influence on pulmonary delivery of rifampicin liposomesRecent advances in nanoparticle formulation of oleanolic acid.Nano-based theranostics for chronic obstructive lung diseases: challenges and therapeutic potential.Design, characterization, and aerosolization of organic solution advanced spray-dried moxifloxacin and ofloxacin dipalmitoylphosphatidylcholine (DPPC) microparticulate/nanoparticulate powders for pulmonary inhalation aerosol delivery.Recent advances in exosome-based nanovehicles as RNA interference therapeutic carriers.An Inhalable Powder Formulation Based on Micro- and Nanoparticles Containing 5-Fluorouracil for the Treatment of Metastatic Melanoma.A Potential Nanomedicine Consisting of Heparin-Loaded Polysaccharide Nanocarriers for the Treatment of Asthma
P2860
Q28383130-3B776369-D341-4584-B311-D33EB52E0466Q33962567-2763E85E-7C9D-4C76-9B68-E7C3C2BC7FBCQ34469273-05BD43C4-F12A-4298-8B25-4A216081206DQ34910919-A4D7541A-AEAD-44D0-9CD1-D7EB650332BAQ35031755-162AB788-93D8-4284-83DC-22CC2A38F589Q35680554-99FFFD59-3E04-4E7E-9CC2-0A760E93A625Q36302124-40186A7C-00D5-42E1-85BC-88E2A49367A3Q37935557-8EAEE44B-8BA4-43D8-9190-92E8F50A6763Q37949386-DE45ADF7-BA07-4E1C-807C-BEFA485CB023Q37978509-297A01E8-422B-4064-BA7F-198AE4D0AAADQ38033610-728DA49F-BA1B-4944-99C0-D025D4FCA0ABQ38498038-04A7B425-EE27-4CE6-9B56-9CEF6E2E4F41Q39084192-2622F27E-FD2A-4071-B446-E45BCC94DD95Q40018943-4D1939C8-F793-41BD-AE64-F68069CF67D0Q41208888-3FBD416E-036F-4405-8612-107B569C6C60Q41275250-DB4A3A4B-41F8-471A-8F00-D60BCD07A2A2Q42087785-C3DA38E7-3300-4EDB-A411-065CC82E2BB2Q42774007-6AEF0ED5-BBEF-4571-9DA6-600E8B5121E0Q42873072-7D27387B-ACF7-4F9E-867A-3C2446465898Q42961541-56F7C157-60C4-4BE9-9D24-58AED72C1E3DQ45872562-04E850F2-D463-49F2-B749-1170CBFDF771Q48132700-C738ECCA-8D23-4834-A2BE-903A20BE35C3Q56992635-4206B766-AE03-4BFA-87B6-F3E4F6802787
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Micro- and nanocarrier-mediated lung targeting.
@en
Micro- and nanocarrier-mediated lung targeting.
@nl
type
label
Micro- and nanocarrier-mediated lung targeting.
@en
Micro- and nanocarrier-mediated lung targeting.
@nl
prefLabel
Micro- and nanocarrier-mediated lung targeting.
@en
Micro- and nanocarrier-mediated lung targeting.
@nl
P2093
P2860
P1476
Micro- and nanocarrier-mediated lung targeting.
@en
P2093
Balak D Kurmi
Jitendra Kayat
Narendra K Jain
Rakesh K Tekade
Virendra Gajbhiye
P2860
P304
P356
10.1517/17425247.2010.492212
P407
P577
2010-07-01T00:00:00Z